BCL7B | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
natural killer cell	9 studies	22% ± 6%	Explore
CD16-negative, CD56-bright natural killer cell, human	8 studies	18% ± 2%	Explore
CD8-positive, alpha-beta T cell	8 studies	20% ± 6%	Explore
gamma-delta T cell	8 studies	21% ± 7%	Explore
B cell	7 studies	24% ± 6%	Explore
CD16-positive, CD56-dim natural killer cell, human	7 studies	20% ± 4%	Explore
CD4-positive, alpha-beta T cell	7 studies	20% ± 5%	Explore
non-classical monocyte	6 studies	32% ± 14%	Explore
mucosal invariant T cell	6 studies	19% ± 4%	Explore
endothelial cell	6 studies	27% ± 7%	Explore
classical monocyte	5 studies	26% ± 9%	Explore
smooth muscle cell	5 studies	18% ± 1%	Explore
memory B cell	5 studies	21% ± 4%	Explore
T cell	5 studies	18% ± 4%	Explore
regulatory T cell	5 studies	17% ± 2%	Explore
effector memory CD8-positive, alpha-beta T cell	4 studies	25% ± 11%	Explore
mature NK T cell	4 studies	16% ± 1%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	4 studies	20% ± 4%	Explore
naive B cell	4 studies	21% ± 4%	Explore
myeloid cell	4 studies	24% ± 7%	Explore
epithelial cell	4 studies	35% ± 13%	Explore
ciliated cell	4 studies	25% ± 5%	Explore
CD8-positive, alpha-beta memory T cell	4 studies	26% ± 4%	Explore
pancreatic A cell	3 studies	29% ± 4%	Explore
conventional dendritic cell	3 studies	35% ± 10%	Explore
hematopoietic precursor cell	3 studies	21% ± 8%	Explore
fibroblast	3 studies	22% ± 4%	Explore
innate lymphoid cell	3 studies	17% ± 1%	Explore
dendritic cell	3 studies	35% ± 23%	Explore
effector memory CD4-positive, alpha-beta T cell	3 studies	23% ± 10%	Explore
basal cell	3 studies	24% ± 7%	Explore
mast cell	3 studies	18% ± 1%	Explore
plasmacytoid dendritic cell	3 studies	25% ± 5%	Explore
CD4-positive, alpha-beta memory T cell	3 studies	20% ± 2%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	6 studies	25% ± 7%	Explore
pancreas	3 studies	29% ± 4%	Explore
lung	3 studies	23% ± 5%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
esophagus	100%	4192.21	1445 / 1445	100%	49.77	183 / 183
intestine	100%	4365.35	966 / 966	100%	54.95	527 / 527
liver	100%	1787.62	226 / 226	100%	37.39	406 / 406
ovary	100%	1734.52	180 / 180	100%	55.85	430 / 430
stomach	100%	2700.42	359 / 359	100%	52.78	286 / 286
thymus	100%	2880.22	653 / 653	100%	60.28	605 / 605
uterus	100%	2465.66	170 / 170	100%	58.01	459 / 459
skin	100%	2138.90	1808 / 1809	100%	60.30	472 / 472
brain	100%	3096.79	2640 / 2642	100%	63.93	705 / 705
lung	100%	3361.82	578 / 578	100%	56.37	1154 / 1155
kidney	100%	2832.81	89 / 89	100%	60.21	900 / 901
bladder	100%	3735.05	21 / 21	100%	54.89	503 / 504
prostate	100%	3135.28	245 / 245	100%	48.60	501 / 502
breast	100%	3159.12	459 / 459	100%	52.47	1114 / 1118
adrenal gland	100%	2990.49	258 / 258	100%	54.23	229 / 230
pancreas	97%	1191.76	317 / 328	100%	56.87	178 / 178
adipose	100%	3571.30	1204 / 1204	0%	0	0 / 0
blood vessel	100%	4437.71	1335 / 1335	0%	0	0 / 0
eye	0%	0	0 / 0	100%	41.68	80 / 80
lymph node	0%	0	0 / 0	100%	68.57	29 / 29
muscle	100%	4479.81	803 / 803	0%	0	0 / 0
spleen	100%	3091.50	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	50.98	45 / 45
ureter	0%	0	0 / 0	100%	27.32	1 / 1
heart	99%	3183.51	856 / 861	0%	0	0 / 0
peripheral blood	93%	1814.45	867 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0030071	Biological process	regulation of mitotic metaphase/anaphase transition
GO_0006357	Biological process	regulation of transcription by RNA polymerase II
GO_2000045	Biological process	regulation of G1/S transition of mitotic cell cycle
GO_0008150	Biological process	biological_process
GO_0006338	Biological process	chromatin remodeling
GO_0070316	Biological process	regulation of G0 to G1 transition
GO_1902459	Biological process	positive regulation of stem cell population maintenance
GO_0030154	Biological process	cell differentiation
GO_2000819	Biological process	regulation of nucleotide-excision repair
GO_0006915	Biological process	apoptotic process
GO_0045596	Biological process	negative regulation of cell differentiation
GO_0008284	Biological process	positive regulation of cell population proliferation
GO_0016055	Biological process	Wnt signaling pathway
GO_2000781	Biological process	positive regulation of double-strand break repair
GO_0140288	Cellular component	GBAF complex
GO_0016514	Cellular component	SWI/SNF complex
GO_0000785	Cellular component	chromatin
GO_0005515	Molecular function	protein binding
GO_0003779	Molecular function	actin binding

IV. Literature review

[source]

Gene name	BCL7B
Protein name	B-cell CLL/lymphoma 7 protein family member B (allergen Hom s 3) B-cell CLL/lymphoma 7B, isoform CRA_a (BAF chromatin remodeling complex subunit BCL7B) BAF chromatin remodeling complex subunit BCL7B
Synonyms	hCG_18986
Description	FUNCTION: Positive regulator of apoptosis. Plays a role in the Wnt signaling pathway, negatively regulating the expression of Wnt signaling components CTNNB1 and HMGA1 . Involved in cell cycle progression, maintenance of the nuclear structure and stem cell differentiation . May play a role in lung tumor development or progression (By similarity). .
Accessions	F2Z3H6 ENST00000223368.7 [Q9BQE9-1] ENST00000455335.2 ENST00000454871.5 ENST00000411832.5 [Q9BQE9-4] F8WE18 Q9BQE9 F8WDZ4 ENST00000448175.5

BCL7B report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review